Navid Sobhani

Scientist, Ph.D.


Curriculum vitae


[email protected]


Department of Cancer Biology

UT MD Anderson Cancer Center



MR1-Restricted T Cells in Cancer Immunotherapy


Journal article


Pedro Flores-Villanueva, Navid Sobhani, Xu Wang, Yong Li
Cancers, vol. 12(8), 2020, p. 2145


Cite

Cite

APA   Click to copy
Flores-Villanueva, P., Sobhani, N., Wang, X., & Li, Y. (2020). MR1-Restricted T Cells in Cancer Immunotherapy. Cancers, 12(8), 2145. https://doi.org/10.3390/cancers12082145


Chicago/Turabian   Click to copy
Flores-Villanueva, Pedro, Navid Sobhani, Xu Wang, and Yong Li. “MR1-Restricted T Cells in Cancer Immunotherapy.” Cancers 12, no. 8 (2020): 2145.


MLA   Click to copy
Flores-Villanueva, Pedro, et al. “MR1-Restricted T Cells in Cancer Immunotherapy.” Cancers, vol. 12, no. 8, 2020, p. 2145, doi:10.3390/cancers12082145.


BibTeX   Click to copy

@article{pedro2020a,
  title = {MR1-Restricted T Cells in Cancer Immunotherapy},
  year = {2020},
  issue = {8},
  journal = {Cancers},
  pages = {2145},
  volume = {12},
  doi = {10.3390/cancers12082145},
  author = {Flores-Villanueva, Pedro and Sobhani, Navid and Wang, Xu and Li, Yong}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in